Clinical and basic research implications of the article ‘IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer’

in Endocrine-Related Cancer
Authors:
Isabel Heidegger Department of Urology, Medical University Innsbruck, Innsbruck, Austria

Search for other papers by Isabel Heidegger in
Current site
Google Scholar
PubMed Close
https://orcid.org/0000-0003-1517-5746
and
Zoran Culig Department of Urology, Medical University Innsbruck, Innsbruck, Austria

Search for other papers by Zoran Culig in
Current site
Google Scholar
PubMed Close

Correspondence should be addressed to I Heidegger: Isabel-maria.heidegger@i-med.ac.at
DOI:
https://doi.org/10.1530/ERC-23-0362
Volume/Issue:
Volume 31: Issue 5
Article Type:
Letter
Article ID:
e230362
Online Publication Date:
22 Mar 2024
Copyright:
© the author(s) 2024
A RELATED ARTICLE IS AVAILABLE
Restricted access
Rent on DeepDyve

Sign up for journal news

Endocrine-Related Cancer is committed to supporting researchers in demonstrating the impact of their articles published in the journal.

The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.

More information is on the Reasons to publish page.

Sept 2018 onwards Past Year Past 30 Days
Full Text Views 37 37 0
PDF Downloads 35 35 0

 

  • Collapse
  • Expand
Print ISSN:
1351-0088
Online ISSN:
1479-6821
Copyright:
© the author(s) 2024
Article ID:
e230362
Received Date:
23 Jan 2024
Accepted Date:
05 Mar 2024
Print Publication Date:
01 May 2024
Online Publication Date:
22 Mar 2024

  • Du Y, Long Q, Shi Y, Liu X, Li X, Zeng J, Gong Y, Li L, Wang X & & He D 2015 Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer. Oncology Reports 34 2273–2281. (https://doi.org/10.3892/or.2015.4201)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Heidegger I, Massoner P, Sampson N & & Klocker H 2015 The insulin-like growth factor (IGF) axis as an anticancer target in prostate cancer. Cancer Letters 367 113–121. (https://doi.org/10.1016/j.canlet.2015.07.026)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Liu G, Zhu M, Zhang M & & Pan F 2023 Emerging role of IGF-1 in prostate cancer: a promising biomarker and therapeutic target. Cancers 15 1287. (https://doi.org/10.3390/cancers15041287)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Marin-Aguilera M, Codony-Servat J, Reig Ò, Lozano JJ, Fernandez PL, Pereira MV, Jimenez N, Donovan M, Puig P, Mengual L, et al.2014 Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer. Molecular Cancer Therapeutics 13 1270–1284. (https://doi.org/10.1158/1535-7163.MCT-13-0775)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Mehta HH, Gao Q, Galet C, Paharkova V, Wan J, Said J, Sohn JJ, Lawson G, Cohen P, Cobb LJ, et al.2011 IGFBP-3 is a metastasis suppression gene in prostate cancer. Cancer Research 71 5154–5163. (https://doi.org/10.1158/0008-5472.CAN-10-4513)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Ofer P, Heidegger I, Eder IE, Schöpf B, Neuwirt H, Geley S, Klocker H & & Massoner P 2015 Both IGF1R and INSR knockdown exert antitumorigenic effects in prostate cancer in vitro and in vivo. Molecular Endocrinology 29 1694–1707. (https://doi.org/10.1210/me.2015-1073)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Puhr M, Hoefer J, Schäfer G, Erb HHH, Oh SJ, Klocker H, Heidegger I, Neuwirt H & & Culig Z 2012 Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205. American Journal of Pathology 181 2188–2201. (https://doi.org/10.1016/j.ajpath.2012.08.011)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Ravi P, Wang V, Fichorova RN, McGregor B, Wei XX, Basaria S & & Sweeney CJ 2023 IGF-I axis changes with ADT and docetaxel in metastatic prostate cancer. Endocrine-Related Cancer 30 e230241. (https://doi.org/10.1530/ERC-23-0241)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Sato Y, Chen Z & & Miyazaki K 2007 Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein1/tumor-derived cell adhesion factor/mac25. Cancer Science 98 1055–1063. (https://doi.org/10.1111/j.1349-7006.2007.00502.x)

    • PubMed
    • Search Google Scholar
    • Export Citation

  • Stewart LV & & Weigel NL 2005 Role of insulin-like growth factor binding proteins in 1alpha, 25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells. Prostate 64 9–19. (https://doi.org/10.1002/pros.20212)

    • PubMed
    • Search Google Scholar
    • Export Citation